Asthma: 1987-2007. What have we achieved and what are the persisting challenges?

Primary Care Respiratory Journal

Volumn 16, Issue 3, 2007, Pages 145-148

  Partridge, Martyn R ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Asthma; Challenges; Guidelines; Management; Treatment

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE PLUS FORMOTEROL; NONSTEROID ANTIINFLAMMATORY AGENT; OMALIZUMAB; STEROID;

ASTHMA; HEALTH SERVICE; HUMAN; LUNG FUNCTION; MAINTENANCE THERAPY; PRESCRIPTION; PREVALENCE; REVIEW; SELF CARE;

ADRENERGIC BETA-AGONISTS; ASTHMA; GLUCOCORTICOIDS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PATIENT EDUCATION; PRACTICE GUIDELINES; PREVALENCE; TREATMENT OUTCOME;

EID: 34249985262     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.3132/pcrj.2007.00039     Document Type: Review

References (23)

1. Devenny A, Wassall H, Ninan T, Omran M, Khan SD, Russell G. Respiratory symptoms and atopy in children in Aberdeen: questionnaire studies of a defined school population repeated over 35 years. BMJ 2004;329(7464):489- 90.
2. Smith MJ, Hodson ME. High-dose beclomethasone inhaler in the treatment of asthma. Lancet 1983;5(1):265-9.
3. Mullarkey MF, Blumenstein BA, Andrade WP, Bailey GA, Olason I, Wetzel CE. Methotrexate in the treatment of corticosteroid-dependent asthma. A doubleblind crossover study. N Engl J Med 1988;318(10):603-07.
4. Beynon HL, Garbett ND, Barnes PJ. Severe premenstrual exacerbations of asthma: effect of intramuscular progesterone. Lancet 1988;2(8607): 370-2.
5. Delivery systems for inhaled drugs in asthma. Drug Ther Bull 1989;27(17):65-8.
6. Allen MB, Ray SG, Leitch AG, Dhillon B, Cullen B. Steroid aerosols and cataract formation. BMJ 1989;299(6696):432-3.
7. Crane J, Pearce N, Flatt A, et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet 1989;1(8644):917-22.
8. British Thoracic Society, Research Unit of the Royal College of Physicians of London, Kings' Fund Centre, National Asthma Campaign. Guidelines for management of asthma in adults: 1 - Chronic persistent asthma. BMJ 1990;301:651-3.
9. Laitinen LA, Heino M, Laitinen A, Kava T, Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985;131(4):599-606.
10. Haahtela T, Jarvinen M, Kava T, et al. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991;325(6):388-92.
11. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 1994;344(8917):219-24.
12. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996;153(5):1481-8.
13. British Thoracic Society, Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. Thorax 2003;58:i1-i94.
14. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000;16(5):802-07.
15. Partridge MR, van der MT, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006;6:13.
16. Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004;170(8):836-44.
17. Holgate ST, Chuchalin AG, Hebert J, et al. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy 2004;34(4):632-8.
18. Brown RH, Wizeman W, Danek C, Mitzner W. Effect of bronchial thermoplasty on airway distensibility. Eur Respir J 2005;26(2):277-82.
19. O'Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005;171(2):129-36.
20. Roberts NJ, Robinson DS, Partridge MR. How is difficult asthma managed? Eur Respir J 2006;28(5):968-73.
21. Haughney J, Barnes G, Partridge M, Cleland J. The Living and Breathing Study: A study of patients' views of asthma and its treatment. Prim Care Resp J 2004;13(1):28-35. doi:10.1016/j.pcrj.2003.11.007
22. Feeney CL, Roberts NJ, Partridge MR. Do medical outpatients want 'out of hours' clinics? BMC Health Serv Res 2005;5(1):47.
23. Pinnock H, Bawden R, Proctor S, et al. Accessibility, acceptability, and effectiveness in primary care of routine telephone review of asthma: pragmatic, randomised controlled trial. BMJ 2003;326:477- 9.